Our Scientific Focus
Introduction to epitranscriptomics
Accent President Robert Copeland explains epitranscriptomics and the Accent mission to translate this extraordinary new area of biology into life-changing cancer therapies
Publications
Boriack-Sjodin, P. A., Ribich, S., & Copeland, R. A. RNA-Modifying Proteins as Anticancer Drug Targets. doi:10.1038/nrd.2018.71. Nature Reviews Drug Discovery.
Weng, H., Huang, H., Wu, H., Qin, X., Zhao, B. S., Dong, L., . . . Chen, J. METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification. Cell Stem Cell, 22(2), 191-205, doi: 10.1016/j.stem.2017.11.016 (2018).
Copeland, R. A., & Boriack-Sjodin, P. A. The Elements of Translational Chemical Biology. Cell Chemical Biology, 25(2), 128-134, doi:10.1016/j.chembiol.2017.11.003 (2018).
» View all publications